(Q46875711)

26 December 2017

title

Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival (English)

1 reference

26 December 2017

1 reference

Roderick M Quiros

1

1 reference

26 December 2017

Geetha Rao

2

1 reference

26 December 2017

Janet Plate

3

1 reference

26 December 2017

Jules E Harris

4

1 reference

26 December 2017

Gregory J Brunn

5

1 reference

26 December 2017

Jeffrey L Platt

6

1 reference

26 December 2017

Paolo Gattuso

7

1 reference

26 December 2017

Richard A Prinz

8

1 reference

26 December 2017

Xiulong Xu

9

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

106

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

532-540

1 reference

26 December 2017

A rapid quantitative assay for the detection of mammalian heparanase activity

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

Human platelet heparanase: purification, characterization and catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Clear cell carcinoma of the pancreas: an adenocarcinoma with ductal phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.21648

1 reference

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.21648

1 reference

7 January 2021

New applications of gemcitabine and future directions in the management of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Human heparanase. Purification, characterization, cloning, and expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparanase expression in invasive trophoblasts and acute vascular damage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparan sulfate: growth control with a restricted sequence menu

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Regulation of platelet heparanase during inflammation: role of pH and proteinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heterodimer formation is essential for heparanase enzymatic activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Human heparanase-1 gene expression in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Expression of heparanase in oral cancer cell lines and oral cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Platelet heparanase in vascular responses to xenotransplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Subcellular localization of heparanase in human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

siRNAs: mechanism of RNA interference, in vivo and potential clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Chronic pancreatitis and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21648

7 January 2021

Identifiers

DOI

10.1002/CNCR.21648

1 reference

26 December 2017

1 reference

26 December 2017